Ameriprise’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.7M Sell
1,607,751
-610,628
-28% -$12.9M 0.01% 1085
2025
Q4
$46.8M Buy
2,218,379
+141,607
+7% +$3M 0.01% 920
2025
Q3
$44.1M Buy
2,076,772
+511,560
+33% +$10.8M 0.01% 957
2025
Q2
$32.8M Buy
1,565,212
+260,759
+20% +$5.39M 0.01% 1085
2025
Q1
$27.1M Buy
1,304,453
+511,890
+65% +$10.5M 0.01% 1144
2024
Q4
$16.1M Buy
792,563
+458,522
+137% +$9.48M ﹤0.01% 1481
2024
Q3
$7.06M Buy
334,041
+29,156
+10% +$608K ﹤0.01% 2118
2024
Q2
$6.19M Buy
304,885
+27,582
+10% +$557K ﹤0.01% 2144
2024
Q1
$5.62M Buy
277,303
+60,649
+28% +$1.24M ﹤0.01% 2280
2023
Q4
$4.5M Buy
216,654
+199,406
+1,156% +$3.93M ﹤0.01% 2424
2023
Q3
$334K Buy
+17,248
New +$343K ﹤0.01% 3556

Other funds holding IBDW

Ameriprise's IBDW Position: Q1 2026 in Review

Ameriprise reduced its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 28% in Q1 2026, selling an estimated $12.9M and leaving 1,607,751 shares worth $33.7M. The position accounts for 0.01% of the portfolio, ranked #1085.

Ameriprise first reported a position in IBDW in Q3 2023 and has held it in 11 quarters since. The position peaked at $46.8M in Q4 2025. 288 funds tracked by Wall St. Rank hold IBDW as of Q1 2026.

  • Ameriprise held 1,607,751 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $33.7M as of Q1 2026.
  • Ameriprise sold 610,628 iShares iBonds Dec 2031 Term Corporate ETF shares in Q1 2026, an estimated $12.9M.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 0.01% of Ameriprise's portfolio in Q1 2026, its #1085 holding.
  • Ameriprise first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q3 2023 and has held it in 11 quarters since.
  • Ameriprise's iShares iBonds Dec 2031 Term Corporate ETF position peaked at $46.8M in Q4 2025.
  • 288 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.